Clinical Trial Update: Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study. [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating whether extending oral anticoagulant therapy after a first idiopathic pulmonary embolism improves outcomes. The study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: University Hospital, Brest | Conditions: Pulmonary Embolism | Phase 3 | Status: COMPLETED